RT Journal Article
SR Electronic
T1 A cohort of patients with COVID-19 in a major teaching hospital in Europe
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.29.20080853
DO 10.1101/2020.04.29.20080853
A1 Alberto M. Borobia
A1 Antonio J. Carcas
A1 Francisco Arnalich
A1 Rodolfo Álvarez-Sala
A1 Jaime Montserrat
A1 Manuel Quintana
A1 Juan Carlos Figueira
A1 Rosario M. Torres Santos-Olmo
A1 Julio García-Rodríguez
A1 Alberto Martín-Vega
A1 Antonio Buño
A1 Elena Ramírez
A1 Gonzalo Martínez-Alés
A1 Nicolás García-Arenzana Les
A1 Milagros Martí-de-Gracia
A1 Francisco Moreno Ramos
A1 Francisco Reinoso-Barbero
A1 Alejandro Martin-Quiros
A1 Angélica Rivera Núñez
A1 Jesús Mingorance
A1 Carlos J Carpio Segura
A1 Daniel Prieto Arribas
A1 Esther Rey Cuevas
A1 Concepción Prados Sánchez
A1 Juan J. Rios
A1 Miguel A. Hernán
A1 Jesús Frías
A1 José R Arribas
A1 for the COVID@HULP Working Group
YR 2020
UL http://medrxiv.org/content/early/2020/05/04/2020.04.29.20080853.abstract
AB BACKGROUND Since the confirmation of the first patient infected with SARS-CoV-2 in Spain in January 2020, the epidemic has grown rapidly, with the greatest impact on the Madrid region. This article describes the first 2226 consecutive adult patients with COVID-19 admitted to the La Paz University Hospital in Madrid.METHODS Our cohort included all consecutively admitted patients who were hospitalized and who had a final outcome (death or discharge) in a 1286-bed hospital of Madrid (Spain) from February 25th (first case admitted) to April 19th, 2020. Data was entered manually into an electronic case report form, which was monitored prior to the analysis.RESULTS We consecutively included 2226 adult patients admitted to the hospital who either died (460) or were discharged (1766). The patients’ median age was 61 years; 51.8% were women. The most common comorbidity was arterial hypertension (41.3%). The most common symptom on admission were fever (71.2%). The median time from disease onset to hospital admission was 6 days. Overall mortality was 20.7% and was higher in men (26.6% vs 15.1%). Seventy-five patients with a final outcome were transferred to the ICU (3.4%). Most patients admitted to the ICU were men, and the median age was 64 years. Baseline laboratory values on admission were consistent with an impaired immune-inflammatory profile.CONCLUSIONS We provide a description of the first large cohort of hospitalized patients with COVID-19 in Europe. Advanced age, male gender, the presence of comorbidities and abnormal laboratory values were more common among the patients with fatal outcomes.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo fundedAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNA